Literature DB >> 31925801

Liver Diseases in the Perinatal Period: Interactions Between Mother and Infant.

Samar H Ibrahim1, Maureen M Jonas2, Sarah A Taylor3, Luz Helena Gutierrez Sanchez4, Jaqueline L Wolf5, Shikha S Sundaram6.   

Abstract

Liver diseases affecting the mother and infant dyad may present in the perinatal period from 20 weeks of gestation to 28 days of life. This review will focus on the current approach to neonatal acute liver failure and the progress made in the diagnosis and management of gestational alloimmune liver disease. It will highlight mother-to-child transmission of viral hepatitis, both management and public health implications. Emerging concepts implicating maternal obesity and nutrition in the development of a rapidly progressive nonalcoholic steatohepatitis phenotype in the offspring will be discussed. Finally, the presentation and management of acute fatty liver of pregnancy and intrahepatic cholestasis of pregnancy, and their impact on the fetus, will be reviewed.
© 2020 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2020        PMID: 31925801      PMCID: PMC7150638          DOI: 10.1002/hep.31109

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  54 in total

1.  Control of iron metabolism--lessons from neonatal hemochromatosis.

Authors:  Heinz Zoller; A S Knisely
Journal:  J Hepatol       Date:  2012-03-05       Impact factor: 25.083

2.  Fetal fatty acid oxidation defects and maternal liver disease in pregnancy.

Authors:  Marsha F Browning; Harvey L Levy; Louise E Wilkins-Haug; Cecilia Larson; Vivian E Shih
Journal:  Obstet Gynecol       Date:  2006-01       Impact factor: 7.661

Review 3.  Intrahepatic cholestasis of pregnancy: Review of six national and regional guidelines.

Authors:  Matthew J Bicocca; Jeffrey D Sperling; Suneet P Chauhan
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2018-10-26       Impact factor: 2.435

4.  Viral hepatitis: 'Immune tolerance' in HBV infection: danger lurks.

Authors:  Wai-Kay Seto; Man-Fung Yuen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-09-14       Impact factor: 46.802

Review 5.  Acute Fatty Liver Disease of Pregnancy: Updates in Pathogenesis, Diagnosis, and Management.

Authors:  Joy Liu; Tara T Ghaziani; Jacqueline L Wolf
Journal:  Am J Gastroenterol       Date:  2017-03-14       Impact factor: 10.864

6.  Transgenerational effects of prenatal exposure to the 1944-45 Dutch famine.

Authors:  M V E Veenendaal; R C Painter; S R de Rooij; P M M Bossuyt; J A M van der Post; P D Gluckman; M A Hanson; T J Roseboom
Journal:  BJOG       Date:  2013-01-24       Impact factor: 6.531

7.  A protective effect of breastfeeding on the progression of non-alcoholic fatty liver disease.

Authors:  V Nobili; G Bedogni; A Alisi; A Pietrobattista; A Alterio; C Tiribelli; C Agostoni
Journal:  Arch Dis Child       Date:  2009-06-24       Impact factor: 3.791

8.  Primary prevention of gestational diabetes mellitus and large-for-gestational-age newborns by lifestyle counseling: a cluster-randomized controlled trial.

Authors:  Riitta Luoto; Tarja I Kinnunen; Minna Aittasalo; Päivi Kolu; Jani Raitanen; Katriina Ojala; Kirsi Mansikkamäki; Satu Lamberg; Tommi Vasankari; Tanja Komulainen; Sirkku Tulokas
Journal:  PLoS Med       Date:  2011-05-17       Impact factor: 11.069

9.  Incidence of Primary Mitochondrial Disease in Children Younger Than 2 Years Presenting With Acute Liver Failure.

Authors:  Patrick McKiernan; Sarah Ball; Saikat Santra; Katherine Foster; Carl Fratter; Joanna Poulton; Kate Craig; Robert McFarland; Shamima Rahman; Iain Hargreaves; Girish Gupte; Khalid Sharif; Robert W Taylor
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-12       Impact factor: 2.839

Review 10.  Mechanisms and Prevention of Vertical Transmission in Chronic Viral Hepatitis.

Authors:  Marianna G Mavilia; George Y Wu
Journal:  J Clin Transl Hepatol       Date:  2017-06-07
View more
  1 in total

1.  SARS CoV-2 detected in neonatal stool remote from maternal COVID-19 during pregnancy.

Authors:  Jenny C Jin; Aparna Ananthanarayanan; Julia A Brown; Stephanie L Rager; Yaron Bram; Katherine Z Sanidad; Mohammed Amir; Rebecca N Baergen; Heidi Stuhlmann; Robert E Schwartz; Jeffrey M Perlman; Melody Y Zeng
Journal:  Pediatr Res       Date:  2022-08-19       Impact factor: 3.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.